Rhythm Pharmaceuticals Inc. (RYTM) Ownership

$100.50

$0.8 (-0.79%)
Last update: 01:00 PM EST
Day's range
$99.21
Day's range
$102.35

Rhythm Pharmaceuticals Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
BLACKROCK, INC. 02/12/2026 6.30 M $674.07 M   -0.08% 9.79%
VANGUARD GROUP INC 01/29/2026 6.21 M $664.82 M   24.31% 9.65%
PRIMECAP MANAGEMENT CO/CA/ 02/11/2026 3.48 M $372.36 M   -18.40% 5.41%
STATE STREET CORP 02/13/2026 2.20 M $235.34 M   8.38% 3.42%
GOLDMAN SACHS GROUP INC 02/10/2026 1.83 M $195.98 M   -3.32% 2.85%
FEDERATED HERMES, INC. 02/12/2026 1.62 M $173.82 M   -6.02% 2.52%
JPMORGAN CHASE & CO 02/11/2026 1.42 M $152.42 M   19.86% 2.21%
GEODE CAPITAL MANAGEMENT, LLC 02/09/2026 1.38 M $147.28 M   0.95% 2.14%
WESTFIELD CAPITAL MANAGEMENT CO LP 02/11/2026 1.27 M $135.64 M   18.54% 1.97%
CAPITAL RESEARCH GLOBAL INVESTORS 02/11/2026 985.09 K $105.44 M   64.66% 1.53%
JENNISON ASSOCIATES LLC 01/30/2026 918.57 K $98.32 M   123.20% 1.43%
FRANKLIN RESOURCES INC 02/11/2026 695.74 K $74.47 M   22.54% 1.08%
MORGAN STANLEY 02/13/2026 651.40 K $69.73 M   40.03% 1.01%
LORD, ABBETT & CO. LLC 02/13/2026 619.54 K $66.32 M   7.56% 0.96%
PICTET ASSET MANAGEMENT HOLDING SA 01/29/2026 614.66 K $66.19 M   -10.01% 0.96%
UBS ASSET MANAGEMENT AMERICAS INC 02/13/2026 549.02 K $58.77 M   25.50% 0.85%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 02/13/2026 532.45 K $56.99 M   0.86% 0.83%
CLEARBRIDGE INVESTMENTS, LLC 02/11/2026 506.11 K $54.17 M   4.41% 0.79%
LOOMIS SAYLES & CO L P 02/12/2026 503.90 K $53.94 M   -4.46% 0.78%
SIREN, L.L.C. 02/13/2026 499.98 K $53.52 M   0.00% 0.78%
UBS GROUP AG 01/29/2026 427.24 K $45.73 M   1.64% 0.66%
RENAISSANCE TECHNOLOGIES LLC 02/12/2026 341.19 K $36.52 M   -37.58% 0.53%
BANK OF NEW YORK MELLON CORP 02/10/2026 301.08 K $32.23 M   65.10% 0.47%
SOFINNOVA INVESTMENTS, INC. 02/13/2026 271.39 K $29.05 M   9.89% 0.42%
VOYA INVESTMENT MANAGEMENT LLC 02/12/2026 249.87 K $26.75 M   12.76% 0.39%
BANK OF AMERICA CORP /DE/ 02/17/2026 224.48 K $24.03 M   -3.72% 0.35%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 02/17/2026 212.80 K $22.78 M   -18.03% 0.33%
LOGOS GLOBAL MANAGEMENT LP 02/17/2026 190.00 K $20.34 M   -5.00% 0.30%
MILLENNIUM MANAGEMENT LLC 02/17/2026 186.71 K $19.99 M   40.21% 0.29%
BNP PARIBAS ARBITRAGE, SNC 02/10/2026 164.56 K $17.61 M   -26.43% 0.26%
CITADEL ADVISORS LLC 02/17/2026 153.32 K $16.41 M   15.60% 0.24%
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. 02/10/2026 149.37 K $15.99 M   23.18% 0.23%
FIRST TURN MANAGEMENT, LLC 02/13/2026 146.30 K $15.66 M   100.00% 0.23%
JANE STREET GROUP, LLC 02/12/2026 137.70 K $14.74 M   88.63% 0.21%
M&G PLC 02/12/2026 137.07 K $14.67 M   100.00% 0.21%
SILVERARC CAPITAL MANAGEMENT, LLC 02/12/2026 135.95 K $14.55 M   -63.26% 0.21%
BARCLAYS PLC 02/13/2026 131.44 K $14.07 M   -7.69% 0.20%
DEUTSCHE BANK AG\ 02/11/2026 129.12 K $13.82 M   10.61% 0.20%
UNIVERSAL- BETEILIGUNGS- UND SERVICEGESELLSCHAFT MBH 01/28/2026 123.54 K $13.22 M   21.87% 0.19%
NUVEEN, LLC 02/12/2026 115.93 K $12.41 M   -1.72% 0.18%
CAPITAL WORLD INVESTORS 02/11/2026 115.69 K $12.38 M   100.00% 0.18%
SWISS NATIONAL BANK 02/12/2026 111.30 K $11.91 M   8.80% 0.17%
NEW YORK STATE COMMON RETIREMENT FUND 02/12/2026 93.68 K $10.03 M   24.68% 0.15%
AXIOM INVESTORS LLC /DE 02/11/2026 83.55 K $8.94 M   0.63% 0.13%
ZWEIG-DIMENNA ASSOCIATES LLC 02/10/2026 81.60 K $8.73 M   100.00% 0.13%
NEUBERGER BERMAN GROUP LLC 02/13/2026 73.57 K $7.88 M   -13.56% 0.11%
WELLS FARGO & COMPANY/MN 02/13/2026 72.62 K $7.77 M   54.07% 0.11%
RHUMBLINE ADVISERS 02/13/2026 71.21 K $7.62 B   -13.23% 0.11%
AQR CAPITAL MANAGEMENT LLC 02/17/2026 70.05 K $7.50 M   -12.20% 0.11%
NORGES BANK 02/10/2026 66.21 K $7.09 M   100.00% 0.10%

Rhythm Pharmaceuticals Inc. institutional Ownership - FAQ's

During the previous two years, 258 institutional investors and hedge funds held shares of Rhythm Pharmaceuticals Inc.. The most heavily invested institutionals were:

BlackRock, Inc.: 6.3 M

VANGUARD GROUP INC: 6.21 M

PRIMECAP MANAGEMENT CO/CA/: 3.48 M

STATE STREET CORP: 2.2 M

GOLDMAN SACHS GROUP INC: 1.83 M

FEDERATED HERMES, INC.: 1.62 M

113.51% of Rhythm Pharmaceuticals Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 45.88 M shares in the last 24 months. This purchase volume represents approximately $4.61 B in transactions.